Axios @axios
Sens. Bernie Sanders and Rand Paul’s shared interest in expanding drug importation could emerge as a populist sequel to Democrats’ drug pricing bill next year — and rekindle friction between the hill, pharma and the FDA. https://t.co/aozxcuxTyJ — PolitiTweet.org